Key discussion topics

Pharmaceutical companies strategies

Investment potential of the pharmaceutical markets

Regulatory strategy for the pharmaceutical markets in various countries

Regulatory requirements to registration and re-registration of pharmaceutical drugs

Pharmaceutical drugs pricing

Pharmaceutical drugs labelling

System of pharmaceutical drugs state purchasing

Launch of innovative pharmaceutical drugs: what steps are required from regulators to improve the market attractiveness?

Protection of intellectual property rights: risks for pharmaceutical companies and international experience

Development of the pharmaceutical drugs production: launched investment projects and opportunities for cooperation

Trends in the development of the commercial segment

Pharmaceutical drugs promotion: approaches to relationships with doctors and development of digital channels

We’re always looking for new voices and new ideas. If you think you can contribute to improve the quality of the content, then feel free to share your ideas

Suggest a speaker